Corcept Therapeutics (CORT) Gross Profit Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,488.21% |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | 4.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.66% |
| Dec 31, 2025 | 11.54% |
| Sep 30, 2025 | 13.00% |
| Jun 30, 2025 | 18.43% |
| Mar 31, 2025 | 7.30% |
| Dec 31, 2024 | 34.00% |
| Sep 30, 2024 | 47.33% |
| Jun 30, 2024 | 38.86% |
| Mar 31, 2024 | 38.37% |
| Dec 31, 2023 | 31.46% |
| Sep 30, 2023 | 21.48% |
| Jun 30, 2023 | 13.79% |
| Mar 31, 2023 | 12.80% |
| Dec 31, 2022 | 4.21% |
| Sep 30, 2022 | 5.83% |
| Jun 30, 2022 | 13.15% |
| Mar 31, 2022 | 18.25% |
| Dec 31, 2021 | 15.37% |
| Sep 30, 2021 | 11.45% |
| Jun 30, 2021 | 3.29% |
| Mar 31, 2021 | -14.45% |
| Dec 31, 2020 | -2.29% |
| Sep 30, 2020 | 6.32% |
| Jun 30, 2020 | 23.21% |
| Mar 31, 2020 | 43.69% |
| Dec 31, 2019 | 32.50% |
| Sep 30, 2019 | 26.79% |
| Jun 30, 2019 | 15.90% |
| Mar 31, 2019 | 12.58% |
| Dec 31, 2018 | 25.19% |
| Sep 30, 2018 | 51.09% |
| Jun 30, 2018 | 75.82% |
| Mar 31, 2018 | 109.57% |
| Dec 31, 2017 | 124.18% |
| Sep 30, 2017 | 98.45% |
| Jun 30, 2017 | 80.25% |
| Mar 31, 2017 | 72.14% |
| Dec 31, 2016 | 59.21% |
| Sep 30, 2016 | 61.91% |
| Jun 30, 2016 | 67.56% |
| Mar 31, 2016 | 59.78% |
| Dec 31, 2015 | 66.80% |
| Sep 30, 2015 | 84.55% |
| Jun 30, 2015 | 104.35% |
| Mar 31, 2015 | 131.62% |
| Dec 31, 2014 | 115.96% |
| Sep 30, 2014 | 171.67% |
| Jun 30, 2014 | 201.71% |
| Mar 31, 2014 | 149.32% |
| Dec 31, 2013 | 198.53% |
| Sep 30, 2013 | 151.60% |
| Jun 30, 2013 | 125.88% |